104 related articles for article (PubMed ID: 19551865)
1. The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration.
Thevenard J; Ramont L; Devy J; Brassart B; Dupont-Deshorgue A; Floquet N; Schneider L; Ouchani F; Terryn C; Maquart FX; Monboisse JC; Brassart-Pasco S
Int J Cancer; 2010 Mar; 126(5):1055-66. PubMed ID: 19551865
[TBL] [Abstract][Full Text] [Related]
2. Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin.
Thevenard J; Floquet N; Ramont L; Prost E; Nuzillard JM; Dauchez M; Yezid H; Alix AJ; Maquart FX; Monboisse JC; Brassart-Pasco S
Chem Biol; 2006 Dec; 13(12):1307-15. PubMed ID: 17185226
[TBL] [Abstract][Full Text] [Related]
3. The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent.
Floquet N; Pasco S; Ramont L; Derreumaux P; Laronze JY; Nuzillard JM; Maquart FX; Alix AJ; Monboisse JC
J Biol Chem; 2004 Jan; 279(3):2091-100. PubMed ID: 14583633
[TBL] [Abstract][Full Text] [Related]
4. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.
Pasco S; Ramont L; Venteo L; Pluot M; Maquart FX; Monboisse JC
Exp Cell Res; 2004 Dec; 301(2):251-65. PubMed ID: 15530861
[TBL] [Abstract][Full Text] [Related]
5. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
6. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral distribution of YSNSG cyclopeptide in a mouse melanoma model using microdialysis.
Slimano F; Djerada Z; Guerin J; Bellouch MI; Brassart-Pasco S; Dukic S
Eur J Pharm Sci; 2020 Feb; 143():105201. PubMed ID: 31866565
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK).
Sun T; Zhao N; Ni CS; Zhao XL; Zhang WZ; Su X; Zhang DF; Gu Q; Sun BC
Cancer Lett; 2009 Nov; 285(2):141-50. PubMed ID: 19482420
[TBL] [Abstract][Full Text] [Related]
10. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
[TBL] [Abstract][Full Text] [Related]
11. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
[TBL] [Abstract][Full Text] [Related]
12. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
Maeshima Y; Colorado PC; Kalluri R
J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
Colombo ES; Menicucci G; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
15. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
16. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
17. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
Siveen KS; Kuttan G
Can J Physiol Pharmacol; 2011 Oct; 89(10):691-703. PubMed ID: 21905822
[TBL] [Abstract][Full Text] [Related]
18. A cell-internalizing peptide endows tumstatin7 with enhanced antitumor properties.
Wang F; Zhang R; Li B; Li Q; Zheng H; Lao X
Pharmazie; 2018 Dec; 73(12):715-720. PubMed ID: 30522555
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of novel integrin-targeting peptides on angiogenesis activity in HUVEC cells in vitro.
Liu Y; Li Y; Xu Y
Cell Biochem Funct; 2011 Jul; 29(5):429-35. PubMed ID: 21590697
[TBL] [Abstract][Full Text] [Related]
20. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
